Manufacturer record
Om Biomedic Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Om Biomedic Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between January 2020 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
10 records linked to Om Biomedic Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amlodipine Besylate Tablets IP 5 mg. | TA25-30Mfg 2025-01 · Exp 2026-12 | The sample does not conform to I.P. w.r.t. the tests for AssayAssay | SDTL, AssamState lab | Mar 2026 |
| Codeine Phosphate Syrup IP 15 mg/5ml | LE24-57Mfg 2024-05 · Exp 2026-04 | Assay of Codeine PhosphateAssay | Drugs Testing Laboratory,Shillong,MeghalayaState lab | Aug 2025 |
| Dicyclomine Hydrochloride Tablets IP 10 mg | TK24-08Mfg 2024-11 · Exp 2026-10 | DescriptionDescription | RDTL, GuwahatiCDSCO lab | May 2025 |
| Dexamethasone Oral Solution USP 0.5mg per 5ml | LG24-29Mfg 2024-07 · Exp 2026-06 | AssayAssay | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| DRIED FERROUS SULPHATE & FOLIC ACID TABLETS IP | TC21-74Mfg 2021-03 · Exp 2023-02 | DescriptionDescription | RDTL GuwahatiState lab | Oct 2022 |
| Dried Ferrous Sulphate & Folic Acid Tablets IP | TE22-24Mfg 2022-05 · Exp 2024-04 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2022 |
| Amlodipine Tablets IP | TL20-25Mfg 2020-12 · Exp 2022-11 | AssayAssay | RDTL GuwahatiState lab | Apr 2022 |
| Pantoprazole Gastro- Resistant Tablets I.P. | TA21-11Mfg 2021-01 · Exp 2022-12 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2022 |
| Pantoprazole Gastro Resistant Tablets IP | TD20-16Mfg 2020-04 · Exp 2022-03 | Dissolution (Buffer stage)Dissolution | RDTL GuwahatiState lab | Dec 2021 |
| Fluconazole Tablets | TOH-02Mfg 2019-04 · Exp 2021-03 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Jan 2020 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.